PHMMF
Price:
$86.36
Market Cap:
$1.32B
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and m...[Read more]
Industry
Biotechnology
IPO Date
2016-02-23
Stock Exchange
OTC
Ticker
PHMMF
According to Pharma Mar, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.35B. This represents a change of 6.19% compared to the average of 1.27B of the last 4 quarters.
The mean historical Enterprise Value of Pharma Mar, S.A. over the last ten years is 853.74M. The current 1.35B Enterprise Value has changed 15.76% with respect to the historical average. Over the past ten years (40 quarters), PHMMF's Enterprise Value was at its highest in in the September 2020 quarter at 1.93B. The Enterprise Value was at its lowest in in the December 2018 quarter at 311.80M.
Average
853.74M
Median
798.85M
Minimum
311.51M
Maximum
1.39B
Discovering the peaks and valleys of Pharma Mar, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 175.54%
Maximum Annual Enterprise Value = 1.39B
Minimum Annual Increase = -51.56%
Minimum Annual Enterprise Value = 311.51M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.39B | 87.65% |
| 2023 | 739.38M | -29.81% |
| 2022 | 1.05B | 9.01% |
| 2021 | 966.34M | -23.26% |
| 2020 | 1.26B | 46.71% |
| 2019 | 858.32M | 175.54% |
| 2018 | 311.51M | -51.56% |
| 2017 | 643.05M | -5.30% |
| 2016 | 679.01M | 6.16% |
| 2015 | 639.63M | -3.37% |
The current Enterprise Value of Pharma Mar, S.A. (PHMMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.06B
5-year avg
1.08B
10-year avg
853.74M
Pharma Mar, S.A.’s Enterprise Value is less than Neuren Pharmaceuticals Limited (2.45B), less than Genus plc (1.96B), less than PeptiDream Inc. (181.74B), greater than Oxford Nanopore Technologies plc (1.08B), less than Mesoblast Limited (2.23B), less than CStone Pharmaceuticals (7.45B), less than Green Thumb Industries Inc. (1.94B), greater than Kuros Biosciences AG (1.18B), less than Medacta Group S.A. (3.44B), less than AS ONE Corporation (161.75B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.45B | $1.55B | |
| 1.96B | $2.32B | |
| 181.74B | $1.41B | |
| 1.08B | $1.71B | |
| 2.23B | $1.73B | |
| 7.45B | $1.30B | |
| 1.94B | $1.59B | |
| 1.18B | $1.49B | |
| 3.44B | $1.67B | |
| 161.75B | $1.66B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Mar, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharma Mar, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharma Mar, S.A.'s Enterprise Value?
What is the highest Enterprise Value for Pharma Mar, S.A. (PHMMF)?
What is the 3-year average Enterprise Value for Pharma Mar, S.A. (PHMMF)?
What is the 5-year average Enterprise Value for Pharma Mar, S.A. (PHMMF)?
How does the current Enterprise Value for Pharma Mar, S.A. (PHMMF) compare to its historical average?